臨床血液
Online ISSN : 1882-0824
Print ISSN : 0485-1439
ISSN-L : 0485-1439
症例
Latamoxefが原因と考えられた無顆粒球症の1例
—In vitro Colony Assayを中心に—
宮野 孝一, 河内 暁一, 須藤 善雅, 横山 〓, 佐藤 雄一
著者情報
ジャーナル 認証あり

1988 年 29 巻 2 号 p. 174-179

詳細
抄録
A five-year-old girl with prulent meningitis due to Hemophilus influenzae was treated with Latamoxef, 260mg/kg/day, which induced agranulocytosis. Latamoxef was discontinued. She was referred to our hospital for the management of agranulocytosis in a clean room. Three days after discontinuation of Latamoxef the granulocytes began to appear in the peripheral blood. After recovery from agranulocytosis the influence of Latamoxef on the growth of bone marrow granulocytemacrophage progenitor cells was examined using in vitro colony assay (CFU-C). Latamoxef significantly inhibited CFU-C growth in concentrations from 4×10-5 to 4×10-8 mol/l. The addition of patient's serum collected during the agranulocytic period did not inhibit colony growth further. The serum antineutrophil antibody and HLA antibody were not detected. Latamoxef did not stimulate patient's lymphocyte blastogenesis.
著者関連情報
© 1988 日本臨床血液学会
前の記事 次の記事
feedback
Top